BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:35 PM
Jul 21, 2010
 |  BC Extra  |  Top Story

FDA places TIDE on partial hold

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) suspended new enrollment in the TIDE postmarketing study of Avandia rosiglitazone after FDA placed it on partial clinical hold. Last week,...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >